Gene expression analysis in high risk head and neck squamous cell carcinoma treated with post-operative radiotherapy

Post-operative radiation therapy (PORT) is the standard treatment for patients with head and neck squamous cell carcinoma (HNSCC) having adverse pathological features. Despite PORT, many patients develop relapse causing morbidity and mortality. These specimens are from a high-risk cohort of such patients treated by PORT and are being used to develop gene signatures for therapeutic response. 102 specimens from surgically excised tumors. No replicates.